DEERFIELD, Ill. — Walgreens Infusion Services is now Option Care, an independent company and brand, though Walgreens has retained “significant” minority ownership. Madison Dearborn Partners (MDP), a private equity firm based in Chicago, now owns the lion’s share of the new infusion services provider. Paul Mastrapa, chief executive officer of Option Care and the former
FLINT, Mich. — Diplomat Pharmacy, which posted strong financial results for fiscal 2014, is acquiring BioRx LLC, a specialized pharmacy and infusion services company. Based in Cincinnati, BioRx provides treatments for patients with ultra-orphan and rare, chronic diseases. Terms of the agreement call for Diplomat to buy BioRx for $210 million in cash and $105
DEERFIELD, Ill. — Walgreen Co. has signed a definitive agreement with Madison Dearborn Partners, a private equity firm based in Chicago, under which MDP will acquire a majority interest in Walgreens Infusion Services. One of the nation’s largest providers of home and alternate treatment site infusion services, Walgreens Infusion Services has a footprint that includes 89
